What changed: Undifferentiated pleomorphic sarcoma (UPS)
Every dated change on the records linked to Undifferentiated pleomorphic sarcoma (UPS), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Trial result2Milestone6This record1
September 2026 · 1
2024 · 1
2017 · 3
- 2017Trial resultISG-STS 1001ISG-STS 1001 reported
Standard arm DFS HR ~0.
- 2017MilestoneISG-STS 1001ISG-STS 1001: neoadjuvant epirubicin-ifosfamide improves survival in high-risk limb sarcoma
A milestone in how this cancer is treated.
- 2017MilestonePembrolizumabSARC028: pembrolizumab responses concentrated in UPS and dedifferentiated liposarcoma
A milestone in how this cancer is treated.